Physician

Philip Mark Neal, MD

According to 2025 Medicare claims, Philip Neal, MD (NPI: 1508058892) practices dermatology in the Houma-Bayou Cane-Thibodaux, LA market, with the plurality of this provider's patient population coming from Terrebonne, LA. This provider's primary affiliated billing organization is DUKE NEAL MEDICAL, LLC (NPI: 1194370536; TIN: 84-2526246) and primary practice location at 70360-4046.

Neal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 805 traditional Medicare patients, billed 5,418 HCPCS/CPT codes, and received $254,190 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,947 prescription claims across 704 beneficiaries totaling $674,136 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 44 records totaling $587. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $191,825 to $674,136. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$166K$333K2015 Medicare payment: $245,908 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $244,425 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $286,895 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $332,578 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $278,742 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $246,123 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $230,956 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $234,223 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $251,289 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $254,190 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159936,464$245,908
20161,0926,876$244,425
20171,2367,287$286,895
20181,2447,869$332,578
20191,0586,556$278,742
20208726,078$246,123
20217595,324$230,956
20227785,568$234,223
20237965,663$251,289
20248055,418$254,190

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$337K$674K2015 Drug cost: $191,825 (USD; Tot_Drug_Cst)2016 Drug cost: $182,517 (USD; Tot_Drug_Cst)2017 Drug cost: $200,020 (USD; Tot_Drug_Cst)2018 Drug cost: $236,657 (USD; Tot_Drug_Cst)2019 Drug cost: $125,423 (USD; Tot_Drug_Cst)2020 Drug cost: $302,654 (USD; Tot_Drug_Cst)2021 Drug cost: $246,644 (USD; Tot_Drug_Cst)2022 Drug cost: $337,089 (USD; Tot_Drug_Cst)2023 Drug cost: $425,132 (USD; Tot_Drug_Cst)2024 Drug cost: $674,136 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153961,014$191,825
20164341,104$182,517
20175181,315$200,020
20185371,421$236,657
20195201,394$125,423
20205181,386$302,654
20215391,334$246,644
20226301,580$337,089
20236141,657$425,132
20247041,947$674,136

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more351469$86
17110Destruction of skin growth, 1-14 growths265324$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more409546$59
17000Destruction of precancer skin growth, 1 growth366512$33
17003Destruction of precancer skin growth, 2-14 growths2731,582$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa11700$229,014
Humira(Cf) PenAdalimumab11308$149,528
Dupixent PenDupilumab21588$78,437
Dupixent SyringeDupilumab17482$67,483
Clobetasol PropionateClobetasol Propionate1283,353$5,152

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.44$587ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Philip Mark Neal, MD?

Tedicare shows public-source Medicare data for Philip Mark Neal, MD (NPI 1508058892), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Philip Mark Neal, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Philip Mark Neal, MD?

Philip Mark Neal, MD is linked to DUKE NEAL MEDICAL, LLC (billing NPI 1194370536) in the available physician profile data.

Does Philip Mark Neal, MD have Open Payments data?

Philip Mark Neal, MD has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.